Monkey Pox (mpox) Information Hub
This page provides up to date and concise information on the impact of mpox on AFAO’s members and communities.
This paper outlines considerations that health authorities can use to determine the appropriate level of isolation required to reduce transmission of monkeypox. The paper illustrates how jurisdictions can work with AFAO’s member organisations to communicate with people who have monkeypox about how to prevent sexual and other skin to skin contact with others during isolation.
Published: 6 December 2022
This paper outlines how sex-on-premises venues (SOPVs) may be the site of transmission for the monkeypox virus between gay, bisexual and other men who have sex with men (GBMSM). The paper describes strategies to mitigate the risk of transmission including cleaning the facility and supporting contact tracing. The paper also notes other ways SOPVs can engage more broadly with the public health response to monkeypox.
Published: 21 October 2022
This paper outlines AFAO and ASHM’s policy position on the collection and dissemination of monkeypox surveillance data. This paper notes that states and territories should issue monkeypox surveillance data relating to locally acquired cases as soon as possible as well as data relating to cases among returned travellers.
Published: 10 October 2022
This paper outlines relevant information about the Monkeypox vaccine. It shows how there is a limited supply of these vaccinations available to the community, which has led to logistical and social challenges. This paper describes several strategies to address these challenges such as tailoring outreach to communities, delaying access to second doses and delivering the vaccination intradermally.
Published: 5 October 2022
This paper outlines the minimum services that governments should fund to enable AFAO’s member organisations to be effective in the response to monkeypox. The paper describes the core services that member organisations should be able to provide, which include running independent digital campaigns, community forums, sector forums, peer support and monitoring the media.
Published: 28 September 2022
This paper outlines the appropriate language to refer to monkeypox in external and internal documentation and engagements.
Published: 12 September 2022 (updated 25 January 2023)
This paper outlines AFAO and ASHM’s position that messages to gay, bisexual and other men who have sex with men (GBMSM) about monkeypox should be provided by GBMSM and other members of the LGBTQI+ community. The paper suggests that government and healthcare stakeholders partner with LGBTIA+ health and HIV organisations to provide messages on risk reduction and to avoid stigmatising sexual behaviour.
Published: 8 September 2022
AFAO Monkeypox Community Forum, 10 October 2022
AFAO Monkey Pox Virus (MPXV) Community Sector Forum – 7 June 2022
On 7 June 2022, AFAO hosted a forum for the HIV community workforce on Monkey Pox (MPXV). The forum’s panel included Associate Professor Edwina Wright (Alfred Health), Professor Allen Cheng (infectious diseases physician) and Matt Vaughan (A/Director HIV and Sexual Health Division – ACON Health), along with AFAO’s Deputy CEO Heath Paynter and CEO Adj. Professor Darryl O’Donnell.